Contents
Fast Track Initiative is a venture capital firm in Tokyo that focuses on life sciences and healthcare services. Founded 2004 in Tokyo, Japan by Hiromichi Kimura, it invests in early stage ventures and seed. Its portfolio companies include Cytlimic, PuREC, Modalis Therapeutics, mediPhone, PENTAS,Mentalhealth Technologies, YUKASHIKADO, Braizon Therapeutics, Inc., Modulus Discovery, and RIN Institute. As of April 2020, Fast Track Initiative has made 23 investments. Their most recent investment was on August 9, 2019, when Cytlimic raised ¥1.3B. Fast Track Initiative has had one exit, which was CellSeed.
Timeline
2004
Founded
Invested in
Open in Query Tool
Patents
Open in Query Tool
Funding Rounds Participated In
Open in Query Tool
Further Resources
Title
Author
Link
Type
Date
References
Company attributes
Location
Pitchbook URL
Founded Date
2004
Email Address
message@fti-jp.com
Phone Number
+10358423325
Other attributes
Company Operating Status
Active
